Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

Amid proliferation of digital platforms for documentation and process execution, biopharma companies are exploring new ...

Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...

Earlier this week, it was confirmed that a $380 million partnership between Bristol Myers Squibb (BMS) and contract ...

Bristol Myers Squibb subsidiary RayzeBio has committed to building a radiopharmaceutical manufacturing facility in Whitestown ...

Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...

Genentech will invest $750 million in a fill-finish facility in Oregon, reached a construction milestone in North Carolina, ...

Industry expert Charley Maxwell shares essential strategies for biotech companies navigating Europe's fragmented regulatory ...

An expert from CTMC told BioProcess International how recent projects in Houston speak to the city’s drive to become a ...

The CEO called the achievement a “major milestone” for his company’s global manufacturing strategy.

Sartorius unveils the Sartocon Q Hydrosart 30 kDa mAb cassette, designed to improve efficiency in high-concentration antibody ...

Andelyn Biosciences will use its AAV Curator platform to develop and manufacture AAV9-GM2, a gene therapy for GM2 ...